SEPN vs SYK · rev $46.0M vs P/E 35, rev $6.59B
Septerna, Inc. Common Stock (SEPN) versus Stryker Corporation (SYK) — a side-by-side from cached financials, not a winner call.
Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.
Stryker Corporation (SYK) is a medical devices company listed on NYSE.
Latest reported SEPN revenue for 2025-12-31 was $46.0M. Net income was -$48.9M. Revenue was up 4174.5% from 2024-12-31 to 2025-12-31. SEPN currently screens at market cap $1.61B.
Latest reported SYK revenue for 2026-06-30 was $6.59B. Net income was $1.28B. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
SEPN currently screens at market cap $1.61B. SYK currently screens at market cap $115.45B and trailing P/E 34.9.
Not investment advice. Open the SEPN and SYK stock pages for the full models.
Not investment advice.